Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF FEBRUARY 02, 2003 FBO #0427
SOLICITATION NOTICE

65 -- 65-Sodium Phenylbutyrate

Notice Date
1/31/2003
 
Notice Type
Solicitation Notice
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Research Contracts Br., 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
 
ZIP Code
20852
 
Solicitation Number
RFQ-NCI-30013-NQ
 
Archive Date
2/22/2003
 
Point of Contact
Cynthia Brown, Purchasing Agent, Phone (301) 496-8608, Fax (301) 402-4513, - Caren Rasmussen, Lead Contract Specialist, Phone (301) 402-4509, Fax (301) 402-4513,
 
E-Mail Address
cb106x@nih.gov, cr214i@nih.gov
 
Small Business Set-Aside
Total Small Business
 
Description
The National Cancer Institute(NCI), Developmental Therapeutics Program (DTP), Pharmaceutical Resources Branch (PRB), intends on entering into a sole source contract with Scandinavian Formulas, Inc., 13 N 7th Street, Perkasie, PA 18944 for the purchase of 120 packages each containing 600, one(1) gram strength Enteric coated sodium Phynylbutyrate tablets. PRB, under a Rapid Access to Intervention Development(RAID)mechanism is supporting a pilot clinical study of Phenylbutyrate and Vagancyclovir in patients with Epstein-Barr virus (EBV) positive malignancies. The objective of the study is to determine the rate of EBV lytic phase activation in patients with EBV positive tumors treated with phenylbutyrate; as well as to observe tumor responses for oral phenylbutyrate followed by oral valgancyclovir in patientts with EBV+malignancies, and to determine serum levels of both drugs. This project requires a supply of 72,000 "COATED" 1 gram strength Sodium Phenylbutyrate package in vacuum sealed pouches each containing 600 tablets. Scandinavian Formulas, Inc., is the only source known to the NCI researchers that can provide the requred tablets to complete the planned Phase II pilot study. All rights to this product and trademark triButyrate are owned by Triple Crown America, Inc., US and Fyrklovern Scandinavia AB, Sweden. This is not a request for competitive quotations. However, if any interested party believes it can meet the above requirements, it may submit a statement of capabilities. The capability statement and any other furnished information must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can fully meet the requirements. Capability statements must be received in the contracting office by 1:30 PM EST (Local Washington, DC time) on February 7, 2003. This aciton is pursuant to 41 USC 253 (1) and under the authority of FAR 6.302-1. This requirement will be procured as a commercial item in accordance with FAR part 12. If you have any questions please contact Cynthia Brown, Purchasing Agent, (301) 402-4509. A determination by the Government not to compete this proposed requirement based on responses to this notice is solely within the discretion of the Government. Information received shall be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. The NAICS Code is 325188 and the business size standard is 1,000 employees.
 
Record
SN00250332-W 20030202/030131213318 (fbodaily.com)
 
Source
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.